Expertise in
73
conditions

Dr. Gary L. Pattee

Neurology
4242 Farnam St., Suite 650, 
Omaha, NE 
Accepting New Patients
Expertise in
73
conditions
4242 Farnam St., Suite 650, 
Omaha, NE 

Overview

Gary Pattee is a Neurologist practicing medicine in Omaha, Nebraska.

Dr. Pattee is highly rated in 73 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Paramyotonia Congenita, Myotonic Dystrophy Type 2, and Gastrostomy.

He is actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 4 clinical trials. Dr. Pattee is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in NE

Fellowships

University of Colorado, Neuromuscular - 1991

Hospital Affiliations

Bryan Medical Center
Beatrice Community Hospital & Health Center, Inc

Languages Spoken

English
American Sign Language

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 11 Less Insurance Carriers -

Locations

Neurological Sciences Center at Clarkson Doctors Building North
4242 Farnam St., Suite 650, Omaha, NE 68131

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
Enrollment Status: Withdrawn
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

68 Total Publications

ALSUntangled #84 - ivermectin.
ALSUntangled #84 - ivermectin.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 06, 2026
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required
Before you request

CHI Health Clinic Neurological Institute (Immanuel)

6901 N 72nd St, Ste 2400, 
Omaha, NE 
 (4.9 miles away)
402-717-0070
Languages Spoken:
English, French, Greek
See accepted insurances
Accepting New Patients

Dr. Bernitsas specialized in MS care. Dr. Bernitsas is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Alpers-Huttenlocher Syndrome, and Neuromyelitis Optica. Dr. Bernitsas is board certified in Neurology - American Board Of Psychology & Neurology. Dr. Bernitsas is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Neurological Sciences Center At Clarkson Doctors Building North

4242 Farnam St., Suite 650, 
Omaha, NE 
 (0.1 miles away)
402-559-8600
Languages Spoken:
English, American Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Murman is a Neurologist practicing medicine in Omaha, Nebraska. Dr. Murman is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Primary Progressive Aphasia, and Frontotemporal Dementia. Dr. Murman is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Clarkson Doctors Building North At Nebraska Medical Center

4242 Farnam St, 
Omaha, NE 
 (0.1 miles away)
402-559-8600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Danish Bhatti is a Neurologist practicing medicine in Omaha, Nebraska. Dr. Bhatti is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Primary Orthostatic Tremor, Drug Induced Dyskinesia, Movement Disorders, Parkinson's Disease, and Deep Brain Stimulation. Dr. Bhatti is currently accepting new patients.

Frequently Asked Questions about Dr. Gary L. Pattee

How do I make an appointment with Dr. Gary L. Pattee?

You can book an appointment with Dr. Gary L. Pattee by calling their office at 402-559-8600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gary L. Pattee a top-rated expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary L. Pattee is classified as an Elite expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gary L. Pattee specialize in?

While Dr. Gary L. Pattee is a Neurology, they have specific expertise in Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Paramyotonia Congenita. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Gary L. Pattee participate in research or clinical trials?

Yes. Dr. Gary L. Pattee has published 68 articles and abstracts on conditions like Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). You can view a list of Dr. Gary L. Pattee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gary L. Pattee accept my insurance?

Dr. Gary L. Pattee accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 402-559-8600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pattee's expertise for a condition
ConditionClose
View All 65 Advanced Conditions
View All 88 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile